ModernVivo
Facts
- HQ
- Seattle
- Sectors
- Software Development
- Founded
- 2023
- Type
- Corporation Seattle business license
- Employees
- 6
- Registered name
- ModernVivo Inc Seattle business license
- Stage
- Early Stage
ModernVivo uses AI to analyze millions of animal studies, cutting literature review from weeks to minutes
ModernVivo, a Seattle startup, uses AI to scan millions of published animal studies and related data to help researchers design preclinical drug experiments faster, reducing literature review time from weeks to minutes and aiming to improve experiment quality while using fewer animals.
ModernVivo launches ModernVivo Marketplace on Sept. 15, 2026 to connect preclinical teams with pre-vetted CROs
ModernVivo announced on Sept. 15, 2026 the launch of ModernVivo Marketplace, a service to help preclinical R&D teams find pre-vetted CROs faster for in vivo study design and execution.
Nineteen Startups Graduate from Creative Destruction Lab’s Seattle Accelerator, Raising Over $190 Million Since 2022
Nineteen startups graduated from the Creative Destruction Lab’s nine-month accelerator program in Seattle, hosted at the University of Washington’s Foster School of Business. The cohort includes companies from manufacturing and computational health sectors, and CDL-Seattle startups have collectively raised at least $190 million since 2022.
People
-
Ian Levine Founder, Co-Founder and CEO
